Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × maribavir × 1 year × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 516 Specimen Handling 372 Carboplatin 365 Magnetic Resonance Spectroscopy 323 Cisplatin 315 Nivolumab 305 Cyclophosphamide 294 Paclitaxel 251 Radiotherapy 249 Biopsy 228 Gemcitabine 219 Bevacizumab 211 Dexamethasone 171 durvalumab 164 Rituximab 159 Oxaliplatin 153 Capecitabine 153 venetoclax 150 Fluorouracil 149 atezolizumab 143 Docetaxel 142 Drug Therapy 138 Ipilimumab 132 Etoposide 132 Doxorubicin 131 Prednisone 122 Radiosurgery 120 Lenalidomide 120 Leucovorin 109 Pemetrexed 107

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07014319 2025-12-04

MALMBA

Seoul National University Hospital

Phase 2 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡